Traded Nov 24, 2025 · filed 1 day later
Derivative exercise or conversion — not an open-market buy.
Loading…
Traded Nov 10, 2025 · Filed Nov 12, 2025
Calix's Chief Product Officer sold $1.54M of Calix shares. The filing does not indicate a pre-arranged trading plan.
Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell
open market sale
Code S — open-market or private sale
~$1,539,240
Shares × reported transaction price
12 days after results of Oct 29, 2025, 79 days before results of Jan 28, 2026
Results dates are the company's own 8-K (Item 2.02). Many companies only let insiders trade in a window after results
None found in footnotes
Only flagged when a footnote says so; never inferred
| After | Stock | S&P 500 | Difference |
|---|---|---|---|
| 7 days | −11.5% | −2.9% | −8.6% |
| 30 days | −10.5% | +1.3% | −11.8% |
| 90 days | −12.6% | +3.0% | −15.6% |
| 180 days | −30.8% | +9.8% | −40.7% |
Past results only. Not a forecast.
Traded Nov 24, 2025 · filed 1 day later
Derivative exercise or conversion — not an open-market buy.
Traded Nov 24, 2025 · filed 1 day later
Derivative exercise or conversion — not an open-market buy.
Traded Nov 17, 2025 · filed 1 day later
Derivative exercise or conversion — not an open-market buy.